Top Markets
Coin of the day
Valion Bio, Inc. Valion Bio, Inc.

Valion Bio, Inc.

VBIO
Peringkat dalam Saham #38930
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead... Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Harga Saham
$0.1818
Kapitalisasi Pasar
$752.91K
Perubahan (1 hari)
6.44%
Perubahan (1 tahun)
-94.81%
Negara
US
Perdagangan Valion Bio, Inc. (VBIO)

Kategori

EPS untuk Valion Bio, Inc. (VBIO)
EPS per 2026 TTM: 0
Menurut laporan keuangan terbaru dan harga saham Valion Bio, Inc., EPS perusahaan saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki EPS sebesar 0 sama dengan EPS tahun 2026 sebesar 0.
Riwayat EPS untuk Valion Bio, Inc. dari 2026 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
Tidak cukup data untuk tanggal yang disediakan.
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE